Perspective Therapeutics, Inc. (CATX)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch CATX
See up to 3 months of CATX. The 7-day demo opens the 1M and 3M ranges and puts CATX on your watchlist.
Start 7-day demoLatest CATX insider trades
About Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. files with the SEC under CIK 0000728387 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
CATX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 475,760 | $1.49M |
CATX insider transactions (Form 4)
2921 Form 4 filings on record, the earliest from Nov 26, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lantheus Alpha Therapy, LLC - 10% Owner | Open-market sale | Common Stock | 80,783 | $3.11 footnote F1 | $251K | |
| Lantheus Alpha Therapy, LLC - 10% Owner | Open-market sale | Common Stock | 167,149 | $3.15 footnote F3 | $526K | |
| ||||||
| Lantheus Alpha Therapy, LLC - 10% Owner | Open-market sale | Common Stock | 78,145 footnote F1,F2 | $3.14 footnote F3 | $246K | |
| Lantheus Alpha Therapy, LLC - 10% Owner | Open-market sale | Common Stock | 35,769 footnote F1,F2 | $3.12 footnote F4 | $112K | |
| ||||||
| Lantheus Holdings, Inc. - 10% Owner | Open-market sale | Common Stock | 35,769 | $3.12 footnote F1 | $112K | |
| ||||||
| Lantheus Holdings, Inc. - 10% Owner | Open-market sale | Common Stock | 78,145 footnote F1 | $3.14 footnote F2 | $246K | |
| ||||||
| Maria E. Martinez | Grant or award | Stock option (right to buy) | 50,000 | $0.00 | - | |
| Frank Morich | Grant or award | Stock option (right to buy) | 50,000 | $0.00 | - | |
| Robert F. Williamson III | Grant or award | Stock option (right to buy) | 50,000 | $0.00 | - | |
| Heidi Henson | Grant or award | Stock option (right to buy) | 50,000 | $0.00 | - | |
| Lori A. Woods | Grant or award | Stock option (right to buy) | 50,000 | $0.00 | - | |
| Johan M. Spoor - Officer | Grant or award | Stock option (right to buy) | 735,000 | $0.00 | - | |
| Jonathan Robert Hunt - Officer | Grant or award | Stock option (right to buy) | 90,000 | $0.00 | - | |
| Markus Puhlmann - Officer | Grant or award | Stock option (right to buy) | 150,000 | $0.00 | - | |
| Jonathan Robert Hunt - Officer | Open-market purchase | Common Stock | 11,000 | $2.03 footnote F1 | $22K | |
| ||||||
| Robert F. Williamson III | Open-market purchase | Common Stock | 9,498 | $2.10 | $20K | |
| Joel Sendek - Officer | Grant or award | Stock option (right to buy) | 600,000 | $0.00 | - | |
| Maria E. Martinez | Grant or award | Stock option (right to buy) | 75,000 | $0.00 | - | |
| Heidi Henson | Open-market purchase | Common Stock | 25,975 | $3.85 | $100K | |
| Johan M. Spoor - Officer | Open-market purchase | Common Stock | 8,000 | $3.77 | $30K | |
| Robert F. Williamson III | Open-market purchase | Common Stock | 3,647 | $3.62 | $13K | |
| Robert F. Williamson III | Open-market purchase | Common Stock | 2,619 | $3.67 | $10K | |
| Jonathan Robert Hunt - Officer | Open-market purchase | Common Stock | 400 | $3.55 | $1K | |
| Jonathan Robert Hunt - Officer | Open-market purchase | Common Stock | 29 | $3.94 | $114 | |
| Jonathan Robert Hunt - Officer | Open-market purchase | Common Stock | 2,400 | $3.60 | $9K | |
| Jonathan Robert Hunt - Officer | Open-market purchase | Common Stock | 10,000 | $3.88 | $39K | |
| Johan M. Spoor - Officer | Open-market purchase | Common Stock | 14,500 | $3.78 | $55K | |
| Johan M. Spoor - Officer | Open-market purchase | Common Stock | 5,400 | $3.80 | $21K | |
| Johan M. Spoor - Officer | Open-market purchase | Common Stock | 6,600 | $3.80 | $25K | |
Item 8.01, 9.01
Item 8.01, 9.01
Item 8.01, 9.01
Item 8.01, 9.01
CATX insider trading FAQ
What is the latest insider trade for CATX?
Perspective Therapeutics, Inc. (CATX) had 4 insider filings in the last 90 days, with the most recent on 2026-09-08. The full record for CATX runs to 21 Form 4 filings, the earliest from 2024-11-26. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CATX stock?
No insider purchases of CATX were filed in the last 90 days. 13 purchases are on record for this company.
How many insiders are selling CATX stock?
6 insider sales of CATX were filed in the last 90 days, totaling $1.49M.
Where can I see CATX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CATX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Lantheus Alpha Therapy, LLC view on EDGAR
- - Lantheus Alpha Therapy, LLC view on EDGAR
- - Lantheus Holdings, Inc. view on EDGAR
- - Lantheus Holdings, Inc. view on EDGAR
- - Maria E. Martinez view on EDGAR
- - Frank Morich view on EDGAR
- - Robert F. Williamson III view on EDGAR
- - Heidi Henson view on EDGAR
- - Lori A. Woods view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where CATX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CATX with a 7-day demo
- CATX on your watchlist
- Every CATX Form 4 filing on record
- Up to 3 months of CATX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
